Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells
Carmen Rodriguez1, Vanesa Martín, Federico Herrera
1Department of Morphology and Cell Biology, Faculty of Medicine, University of Oviedo, c/Julian Claveria 6, 33006 Oviedo, Spain. carro@uniovi.es.
Abstract:
It is well established that melatonin exerts antitumoral effects in many cancer types, mostly decreasing cell proliferation at low concentrations. On the other hand, induction of apoptosis by melatonin has been described in the last few years in some particular cancer types. The cytotoxic effect occurs after its administration at high concentrations, and the molecular pathways involved have been only partially determined. Moreover, a synergistic effect has been found in several cancer types when it is administered in combination with chemotherapeutic agents. In the present review, we will summarize published work on the pro-apoptotic effect of melatonin in cancer cells and the reported mechanisms involved in such action. We will also construct a hypothesis on how different cell signaling pathways may relate each other on account for such effect.
Insights
Melatonin shows antitumoral effects by decreasing cancer cell proliferation and inducing apoptosis at high concentrations. It also enhances chemotherapy efficacy, suggesting potential as a cancer treatment adjunct.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Melatonin is known for antitumoral effects, primarily reducing cancer cell proliferation at low concentrations.
- Recent studies show melatonin can induce apoptosis in specific cancer types at high concentrations.
- The molecular mechanisms underlying melatonin's pro-apoptotic effects are not fully understood.
Purpose of the Study:
- To review the pro-apoptotic effects of melatonin in cancer cells.
- To summarize the molecular mechanisms involved in melatonin-induced apoptosis.
- To propose a hypothesis linking cell signaling pathways to melatonin's pro-apoptotic action.
Main Methods:
- Literature review of published studies on melatonin and cancer.
- Analysis of reported molecular pathways involved in melatonin's cytotoxic effects.
- Synthesis of findings to construct a hypothetical model of cell signaling.
Main Results:
- Melatonin exhibits a dose-dependent effect, inhibiting proliferation at low doses and inducing apoptosis at high doses.
- Synergistic anticancer effects observed when melatonin is combined with chemotherapeutic agents.
- Partial elucidation of molecular pathways mediating melatonin's pro-apoptotic action.
Conclusions:
- Melatonin possesses significant pro-apoptotic properties in cancer cells, particularly at higher concentrations.
- Understanding the molecular pathways is crucial for optimizing melatonin-based cancer therapies.
- Further research into cell signaling interactions may reveal novel therapeutic strategies.
More Related Videos
06:42A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice
Published on: April 16, 2018
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Apoptosis
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
